CASES DEATHS CASES DEATHS
December 2020 19,111,443 341,149 2,120,610 24,241
January 26,185,362 441,319 3,310,949 40,702
February 28,602,101 513,137 3,563,578 51,953
March 30,459,874 552,072 3,668,277 59,240
April 32,225,012 574,280 3,742,115 62,078
May 33,261,284 594,468 3,789,227 63,247
June 33,624,871 603,966 3,814,890 63,569
July 34,434,136 610,859 3,903,052 64,231
August 39,057,368* 638,700 4,326,204 65,757
September 43,471,906 698,149 4,720,860 69,130
October 45,979,056 746,021 4,915,796 71,950
UPDATED WEEKLY - Last updated on 28 November 2021, 1:00 pm PST, John Hopkins Corona Virus Dashboard and Worldometer
John Hopkins Worldometer
Recovered - Recovered - 236,345,106
POPULATION - is 333,728,343 as of 28 November 2021, 1:00 pm PST, based on Census U.S. and World Population Clock.
Cases in the U.S.
Recovered - Recovered - 38,870,110
Cases in California
Recovered - Recovered - N/A
The unemployment rate decreased in 27 states, increased in one, and remained unchanged in 36 states including Washington, DC, according to monthly data from the Bureau of Labor Statistics (BLS).
11/28/2021 Cases (WHO) Deaths (WHO) Recovered (WHO)
**reporting information is limited, reduced testing and increased cases
United States progress Updated as of 28 November 2021, 1:00 pm PST
State Progress Updated as of 28 November 2021, 1:00 pm PST
. 1st dose 2nd dose % fully Vaccinated
** Last on vaccine tracker
UPDATE - Thu, November 4, 2021, 7:43 PM
CDC Recommends Pfizer's COVID-19 Vaccine For Children Ages 5 to 11. Families with young children finally have the news they've been waiting for: the Centers for Disease Control and Prevention officially recommends giving Pfizer's child-size dose of the coronavirus vaccine to children ages 5 to 11. This historic decision makes the vaccine available to 28 million children in the US. Nearly the entire population of the nation is now eligible to receive the shot.
The CDC's advisory committee voted unanimously, spoke about their support of the vaccine, noting that their analysis shows how the benefits of the vaccine outweigh any risks for this age group. This announcement comes after the Food and Drug Administration authorized Pfizer-BioNTech's vaccine for children ages 5 to 11 October 29.
This expansion to children indicates parents may be able to protect their children following a tenuous start to the school year, which has seen ramped-up pediatric COVID-19 positivity rates due to the surge of the Delta variant among the unvaccinated. BioNTech said it has laid out plans to seek approval for the vaccine in children between 6 months and 2 years old later this year.
Meanwhile, Moderna expects positive results from its own clinical trial of adolescents aged 12 to 17, and has dosage trials underway for children as young as 6 months old that they hope to submit by year's end.
FDA Authorizes Moderna and Johnson & Johnson Boosters, Allows People to ‘Mix and Match’ COVID-19 Vaccines. Updated: Oct. 29, 2021 12:02 p.m. PT. The FDA authorized a Moderna vaccine booster for Moderna recipients age 65 years of age and older, and adults who are at high risk because of severe illness or exposure in their work setting. Johnson & Johnson recipients age 18 and older will also be able to get a Moderna booster two months after being vaccinated, and will be eligible for Pfizer's booster too. Those eligible can get their shots now.
The CDC recommends the following people get their booster shot six months after they've been fully vaccinated with either Pfizer or Moderna:
UPDATED 10/20 5:12 p.m. ET: The FDA has approved booster shots for the Moderna and Johnson & Johnson vaccines. The federal agency has authorized medical providers to allow people to receive a booster shot that’s different from the vaccine they initially received.
According the National Institutes of Health study on mixing vaccine booster shots presented to the FDA’s advisory panel, the “mix and match” approach looks to offer the most benefits to those who received Johnson & Johnson’s single-dose vaccine shot.
Those who first received the J&J shot then a J&J booster saw antibody levels increase four times. People receiving the J&J shot and later receiving a Moderna booster saw their antibody levels increase 76 times over 15 days. The Pfizer-BioNTech vaccine booster was also more effective in raising antibody levels of people who got the J&J vaccine and booster.
“What the study shows is that regardless of what an individual received originally, getting boosted with one of the three vaccines that we evaluated, led to good antibody responses in each of the groups,” Dr. Robert Atmar of Baylor College of Medicine, an author of the study.
Many who have gotten the initial Pfizer shots six months ago are already getting a booster after the FDA authorized their use last month. While Pfizer’s boosters are only for certain high-risk groups of Americans, Israeli officials credit wider booster use in their country to stemming the delta surge.
“There is no question in my mind that the break of the curve was due to the booster dose,” Alroy-Preis said in response to FDA advisers who noted that other countries have seen a lowering of delta cases without widespread booster use.
Pfizer says its vaccine is 90.7% effective against symptomatic Covid-19 in children ages 5 to 11
Pfizer indicated its vaccine is safe and 90.7% effective against symptomatic Covid-19 in children ages 5 to 11 in documents posted prior to a meeting with the US Food and Drug Administration’s vaccine advisers.
Pfizer/BioNTech are seeking FDA emergency use authorization, EUA, of a two-dose regimen of their 10-microgram dose for children ages 5 to 11. The two doses would be administered three weeks apart. If authorized, this would be the first Covid-19 vaccine for younger children. The Pfizer/BioNTech vaccine is approved for age 16 and older and an EUA for ages 12 to 15.
MODERNA VACCINE. The FDA Panel Endorses Moderna COVID-19 Vaccine Booster Shots For Seniors, High-Risk Groups. U.S. health advisers said some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19. Moderna indicates a single 50-microgram shot should be enough for a booster, half of the two 100-microgram shots. Moderna indicated it would trigger fewer uncomfortable shot reactions such as fever and achiness, while also leaving more vaccine available for the global supply.
U.S. officials stress the priority is to get shots to the 66 million unvaccinated Americans who are eligible for immunization ― the most at risk of the delta variant. “It’s important to remember, the vaccines provide strong protection against serious outcomes” - hospitalization and death - said FDA vaccine chief Dr. Peter Marks.
As the delta variant surged in July and August, those vaccinated had a 36% lower rate of “breakthrough” infections compared with those vaccinated longer ago, Moderna’s Dr. Jacqueline Miller told FDA’s advisers.
Moderna booster backed by advisory panel for elderly, at-risk. A federal advisory committee unanimously supported booster shots of the Moderna COVID-19 vaccine for people 65 and older, as well as younger adults with certain medical conditions or jobs that put them at increased risk for infection. The booster would be half the regular dose, given at least six months after the second shot.
Moderna's booster will be the second one to receive emergency use authorization if the decision is verified by a second advisory group and top officials at the Food and Drug Administration
JOHNSON AND JOHNSON VACCINE.
Vaccine panel recommends J&J boosters after data says vaccine's effectiveness has 'headroom to improve': Live COVID-19 updates. Johnson & Johnson's vaccine should be considered a two-dose vaccine rather than the one-and-done shot that received initial authorization, a federal panel decided. The committee felt the 15 million Americans receiving the single dose of the "one and done" J&J vaccine would be substantially better protected with a second one.
The unanimous decision from the Vaccines and Related Biological Products Advisory Committee came after real-world data showed J&J's one-shot vaccine is not as effective as the Pfizer and Moderna vaccines in real-world studies.
"Because the magnitude is lower than what would be desired – the estimates seen with the mRNA vaccines – there is headroom to improve the efficacy," said Dr. Penny Heaton, head of the vaccines global therapeutic area for Janssen Pharmaceuticals, a Johnson & Johnson company that developed the vaccine.
Adding a second dose 2- to 6-months after the initial J&J shot would provide the same effectiveness as the mRNA vaccines without their fading protection, Heaton told the committee.
FDA to convene independent panel on Merck's COVID pill. The Merck antiviral pill, molnupiravir, is set to be reviewed by an FDA panel on November 30th. Merck officials said their antiviral pill is ready to be produced by the millions by the end of this year. Internal data found the medication reduces hospitalizations by half. Molnupiravir would be the first approved COVID-19 treatment in pill form and could be used globally to help mitigate symptoms for those who contract the virus. Merck has already granted a royalty-free license to a nonprofit backed by the United Nations to manufacture the drug in 105 different nations.
The Food and Drug Administration indicated it would convene a panel of outside experts to review the safety and efficacy data of Merck's pill to treat COVID-19. The group will meet Nov. 30, meaning Merck's pill likely won't receive authorization until December at the earliest. Earlier this month, Merck said its trial data shows the experimental drug prevented half of severe coronavirus infections that would otherwise have sent people to the hospital.
A generic antidepressant might reduce COVID-19 symptoms in severe cases. The antidepressant fluvoxamine, a generic, cheap drug, might reduce severe COVID-19 symptoms by up to a third, according to a trial conducted in Brazil. The drug, a selective serotonin reuptake inhibitor, is typically used for obsessive compulsive disorder and depression, but can have effects on inflammation and clotting in the body. The drug requires further study before officials would consider it for treatment of the virus.
Only foreign nationals who have been fully vaccinated with a drug approved by the U.S. Food and Drug Administration or World Health Organization can enter the country. That list does not include Covaxin.
CDC data shows how much better the vaccinated are faring. In August, the unvaccinated were 11.3 times more likely to die of COVID-19 and 6.1 times more likely to test positive, the real-world data show. On the worst reported week of deaths around Aug. 8, the unvaccinated died at a rate of 13.23 per 100,000, compared to Johnson & Johnson recipients at 3.14, Pfizer at 1.43 and Moderna at 0.73.
The vaccines also dramatically changed COVID-19 outcomes for the elderly compared to the unvaccinated. The fully vaccinated, age 80 or older, were less likely to die of the disease than unvaccinated people in their 50s or early 60s. The vaccinated of every age group were less likely to test positive than any age group of unvaccinated people. The CDC says the data came from 16 governments representing about 30 percent of the population, from Florida to Wisconsin to Utah, as well as New York City.
Florida governor vows to challenge Biden's COVID vaccine mandate. Florida will challenge the Biden administration's vaccine mandate in federal court, Gov. Ron DeSantis said Thursday, vowing that the pending requirement on businesses and hospitals "will go down."
President Joe Biden's mandate expected this month would apply to hospitals that treat Medicare and Medicaid patients and employers with 100 or more employees. Some Florida hospitals already have COVID-19 vaccine requirements in anticipation of the coming federal rule.
Pediatric COVID-19 vaccine likely widely available by November: Officials In a private phone call, the White House urged governors to prepare to begin vaccinating elementary-age kids.
The Biden administration
has purchased 65 million Pfizer pediatric vaccine doses in anticipation of authorization, according to a Health and Human Services official. That is more
than enough to fully vaccinate, two doses each, all 28 million 5 to 11-year-olds.
The Centers for Disease Control surveyed all states and 85% have said they are ready to go or are on track for enrolling providers to give COVID-19 vaccines to kids. Five percent needed assistance with preparations, according to the HHS official.
Friday, October 15 is the deadline to have at least one shot in Philadelphia if you work in hospitals, long-term care, or work or study in higher education. The Philadelphia Department of Public Health isn't seeing a huge rush for first-time shots instead, boosters are gaining steam.
Philadelphia reported about 24,500 booster shots this past week, up about 66% from the week prior.
On CNN, Dr. Anthony Fauci indicated the development of the Merck COVID anti-viral pill which could be on the market, pending FDA and CDC approval could reduce hospitalizations and death by 50%. “It is promising but prevention is still the best policy. It should not be a substitute for preventing infection in the first place, which is why we get vaccines."
COVID-19 live updates: CDC advising states to preorder Pfizer's vaccine for young children.
SAN FRANCISCO (KGO) -- A surge in coronavirus cases has been reported in the Bay Area and across California as well as the country due in part to the emergence of the highly-contagious delta variant.
Here are the latest developments on the respiratory illness in the Bay Area:
Participating businesses, organizations and hosts must verify that all patrons, employees and attendees are fully vaccinated before allowing people inside their facilities not to wear face coverings. There can be no more than 100 persons present at these facilities.
1:35p.m. - BART to require all employees get vaccinated against COVID-19 by Dec. 13. (Bay City News) BART announced it will require all employees and contractors to be vaccinated against COVID-19 or prove their full vaccination status by Dec. 13 under an adopted policy, with an exemption for those who have a valid medical or religious exemption.
"By adopting this policy today, nobody is getting fired tomorrow," Li said. "No one is being forced to get the vaccine, but this policy states that being vaccinated is a condition of employment." BART officials estimated that around 20 to 25 percent of BART's nearly 4,000 employees remain unvaccinated.
U.S. COVID-19 vaccine rates up thanks to mandates; cases and deaths down -officials
Vaccination rates in the United States have risen by more than 20 percentage points after multiple institutions adopted vaccine requirements, while case numbers and deaths from the virus are down indicated Biden administration officials. White House response coordinator Jeff Zients told reporters, ‘77% of eligible Americans had received at least one shot of a vaccine.’
Vaccination rates went up when mandates were put into place by private businesses, healthcare systems, social institutions and state and local governments, he said in a briefing.
President Joe Biden's team has struggled to vanquish the coronavirus pandemic because a large swath of the U.S. population continues to resist taking safe and widely available vaccines.
The Administration announced policies requiring healthcare workers and federal employees to get COVID-19 vaccinations and push large employers to have their workers inoculated or tested weekly. Federal rules to put the mandate into effect are being formalized. Some states and large employers have mandated vaccines already.
"Despite the recent decrease in cases, most communities across the country are still experiencing substantial to high levels of community transmission," Walensky said. "We absolutely need to stay focused on continuing to get COVID under control around the country, especially as we head into the fall and winter season" through masking and vaccinations, she said, “it was not time to let down the country's guard.”
The Occupational Safety and Health Administration, OSHA, was tasked with outlining rules for the vaccine mandate and the agency is expected to bring the mandate forward in the coming weeks.
CDC announces variant-finding testing program at major U.S. airports. The program, limited to passengers on certain international flights coming into San Francisco, JFK and Newark International, is part of an effort to identify new variants from abroad amid fears of a vaccine-resistant strain entering the country.
Early detection will allow medical researchers to quickly begin testing how the new strains spread and react to the vaccines currently in use, officials say. The CDC will be conducting the SFO monitoring program in collaboration with the XpresCheck COVID-19 testing company and Ginkgo Bioworks.
Greg Abbott's Vaccine Mandate Ban Comes as Texas Leads U.S. in Daily COVID Deaths
Texas Governor Gregg Abbott issued an executive order, EO, to prevent the enforcement of vaccine mandates in the state by any entity, including private businesses. Abbott, a Republican, had and threatening fines for local government officials who tried to impose face mask requirements. In a statement accompanying the order, Abbott added: "The COVID-19 vaccine is safe, effective, and our best defense against the virus, but should remain voluntary and never forced."
The new order comes as Texas leads the nation in average daily deaths due to COVID-19 and amid continuing vaccine hesitancy among a section of the U.S. population. Data compiled by The New York Times shows that the average number of daily deaths from COVID-19 in Texas stands at 241.4.
Texas' average is significantly higher than the state with the next highest figure, Florida, which stands at 149.7 average daily deaths. That figure represents data from the seven days up to October 11.
How to Protect Yourself? Getting vaccinated is your best bet!
IT’S NOT OVER!
Stay safe. Mask. Social distance. Frequent hand washing. Avoid crowds
ALWAYS CONSULT YOUR PERSONAL HEALTH CARE PROFESSIONAL
1756 N. Riverside Ave
Rialto, CA 92376
Phone: 909 879-1059
Fax : 909 879-1043
Monday 10 am - 4:00 pm Tuesday 10 am - 4:00 pm
Wednesday 10 am - 4:00 pm
Thursday 10 am - 4:00 pm
Friday 10 am - 4:00 pm
HOLIDAY HOURS MAY VARY
10:30 am - 3 pm
Phone orders are encouraged. Large orders prior to 10:30 am
Deliveries not available during covid restrictions.
Stop in to check out all the items currently discounted for your personal resolutions.